n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier.
Level 5 - mechanism / opinion, no new human data
Level 5 because the study consists solely of bench and animal research (rodent feeding study and primary rat cell culture).
PubMed 18042368 · doi:10.1016/j.plefa.2007.10.011
What was done
The study assessed GLUT1 expression and glucose transport activity in blood-brain barrier endothelial cells under varying n-3 polyunsaturated fatty acid (PUFA) conditions. In vivo, cerebral cortex microvessels were isolated from rats fed low, adequate, or high n-3 PUFA diets to measure GLUT1 protein expression by Western blot and determine maximum binding via cytochalasin B. In vitro, primary cultures of rat brain endothelial cells (RBEC) were supplemented with docosahexaenoic acid (DHA, 15 µM), eicosapentaenoic acid (EPA), or arachidonic acid (AA) to evaluate membrane incorporation and basal glucose transport via [(3)H]-3-O-methylglucose uptake.
What was found
In rat microvessels, GLUT1 protein expression decreased by 23% in n-3 PUFA-deficient animals and increased by 35% in animals fed a high n-3 PUFA diet compared to controls. Cytochalasin B binding indicated reduced GLUT1 Bmax in deficient rats. In vitro, DHA supplementation restored membrane DHA levels to those found in microvessels from rats on high n-3 diets. Treatment of RBEC with DHA or EPA increased [(3)H]-3-O-methylglucose uptake by 35% and 50%, respectively, whereas AA had no effect.
Why it matters
This provides a mechanistic explanation for how dietary omega-3 fatty acids may regulate cerebral energy metabolism by modulating endothelial GLUT1 density and glucose transport capacity across the blood-brain barrier.
Limits
The study is restricted to preclinical rodent and in vitro primary cell models, precluding direct extrapolation to human blood-brain barrier dynamics. The abstract omits sample sizes (number of rats and culture replicates), measures of variance, and exact significance values.
Cited by
- supports In mice, omega-3 deficiency makes cell membranes too stiff, impairing glucose transporters into the brain and leading to the accumulation of tau tangles.